These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35628815)

  • 1. Effectiveness of Dupilumab in the Treatment of Patients with Severe Uncontrolled CRSwNP: A "Real-Life" Observational Study in the First Year of Treatment.
    De Corso E; Settimi S; Montuori C; Corbò M; Passali GC; Porru DP; Lo Verde S; Spanu C; Penazzi D; Di Bella GA; Nucera E; Bonini M; Paludetti G; Galli J
    J Clin Med; 2022 May; 11(10):. PubMed ID: 35628815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
    De Corso E; Pasquini E; Trimarchi M; La Mantia I; Pagella F; Ottaviano G; Garzaro M; Pipolo C; Torretta S; Seccia V; Cantone E; Ciofalo A; Lucidi D; Fadda GL; Pafundi PC; Settimi S; Montuori C; Anastasi F; Pagliuca G; Ghidini A; Cavaliere C; Maffei M; Bussu F; Gallo S; Canevari FRM; Paludetti G; Galli J;
    Allergy; 2023 Oct; 78(10):2669-2683. PubMed ID: 37203259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP.
    De Corso E; Montuori C; Settimi S; Mele DA; Cantiani A; Corbò M; Cantone E; Paludetti G; Galli J
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
    Bachert C; Han JK; Desrosiers M; Hellings PW; Amin N; Lee SE; Mullol J; Greos LS; Bosso JV; Laidlaw TM; Cervin AU; Maspero JF; Hopkins C; Olze H; Canonica GW; Paggiaro P; Cho SH; Fokkens WJ; Fujieda S; Zhang M; Lu X; Fan C; Draikiwicz S; Kamat SA; Khan A; Pirozzi G; Patel N; Graham NMH; Ruddy M; Staudinger H; Weinreich D; Stahl N; Yancopoulos GD; Mannent LP
    Lancet; 2019 Nov; 394(10209):1638-1650. PubMed ID: 31543428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life.
    Nettis E; Brussino L; Patella V; Bonzano L; Detoraki A; Di Leo E; Sirufo MM; Caruso C; Lodi Rizzini F; Conte M; Yacoub MR; Triggiani M; Ridolo E; Macchia L; Rolla G; Brancaccio R; De Paulis A; Spadaro G; Di Bona D; D'Uggento AM; Ginaldi L; Gaeta F; Nucera E; Jaubashi K; Villalta D; Dagna L; Ciotta D; Pucciarini F; Bagnasco D; Celi G; Chieco Bianchi F; Cosmi L; Costantino MT; Crivellaro MA; D'Alò S; Del Biondo P; Del Giacco S; Di Gioacchino M; Di Pietro L; Favero E; Gangemi S; Guarnieri G; Heffler E; Leto Barone MS; Lombardo C; Losa F; Matucci A; Minciullo PL; Parronchi P; Passalacqua G; Pucci S; Rossi O; Salvati L; Schiappoli M; Senna G; Vianello A; Vultaggio A; Baoran Y; Incorvaia C; Canonica GW
    Clin Mol Allergy; 2022 May; 20(1):6. PubMed ID: 35590407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of dupilumab in real-life settings: a STROBE study.
    Gal A; Gravier-Dumonceau R; Penicaud M; Ebode D; Radulesco T; Michel J
    Eur Arch Otorhinolaryngol; 2024 Mar; ():. PubMed ID: 38498194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-life effectiveness of dupilumab in chronic rhinosinusitis with nasal polyps. Results from eight Hungarian centres with 12-month follow-up.
    Kiricsi A; Bella Z; Kraxner H; Szaloki T; Fent Z; Liktor B; Huszka J; Laszlo P; Gobol D; Helfferich F; Vaska Z; Piski Z; Juhasz-Loisch L; Horvath B; Galantai G; Krisztin N; Toth L; Bodi A; Matuz M; Lujber L; Hirschberg A
    Rhinology; 2024 Jun; ():. PubMed ID: 38848046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Dupilumab in the Treatment of Patients with Uncontrolled Severe CRSwNP: A "Real-Life" Observational Study in Naïve and Post-Surgical Patients.
    Ottaviano G; Saccardo T; Roccuzzo G; Bernardi R; Chicco AD; Pendolino AL; Scarpa B; Mairani E; Nicolai P
    J Pers Med; 2022 Sep; 12(9):. PubMed ID: 36143311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olfaction Recovery following Dupilumab Is Independent of Nasal Polyp Reduction in CRSwNP.
    Cantone E; De Corso E; Ricciardiello F; Di Nola C; Grimaldi G; Allocca V; Motta G
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 35893310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps.
    Mullol J; Bachert C; Amin N; Desrosiers M; Hellings PW; Han JK; Jankowski R; Vodicka J; Gevaert P; Daizadeh N; Khan AH; Kamat S; Patel N; Graham NMH; Ruddy M; Staudinger H; Mannent LP
    J Allergy Clin Immunol Pract; 2022 Apr; 10(4):1086-1095.e5. PubMed ID: 34628065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dupilumab Improves Facial Pain and Reduces Rescue Treatments in Patients with CRSwNP and Recalcitrant Frontal Sinusitis.
    De Corso E; Settimi S; Penazzi D; D'Agostino G; Corbò M; Rigante M; Montuori C; Rizzuti A; Pacilli MC; Di Cesare T; Lo Verde S; Rizzi A; Chini R; Galli J
    J Pers Med; 2024 Jul; 14(7):. PubMed ID: 39063989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proposal for a Structured Outpatient Clinic for Dupilumab Treatment in Chronic Rhinosinusitis with Nasal Polyps in the First Year of Treatment.
    Torretta S; De Corso E; Nava N; Fraccaroli F; Ferrucci SM; Settimi S; Montuori C; Porru DP; Spanu C; D'Agostino G; Marzano AV; Pignataro L
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dupilumab: A Review in Chronic Rhinosinusitis with Nasal Polyps.
    Hoy SM
    Drugs; 2020 May; 80(7):711-717. PubMed ID: 32240527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measuring Nasal Patency and the Sense of Smell in CRSwNP Patients Treated with Dupilumab.
    Ottaviano G; De Corso E; Cantone E; Ciofalo A; Saccardo T; Bernardi R; Mairani E; Montuori C; Roccuzzo G; Soldati L; Randon B; Zampollo S; Chicco AD; Visconti F; Scarpa B; Nicolai P
    J Pers Med; 2023 Jan; 13(2):. PubMed ID: 36836468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study.
    Detoraki A; Tremante E; D'Amato M; Calabrese C; Casella C; Maniscalco M; Poto R; Brancaccio R; Boccia M; Martino M; Imperatore C; Spadaro G
    Ther Adv Respir Dis; 2021; 15():17534666211009398. PubMed ID: 33910399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective Study.
    Higo H; Ichikawa H; Arakawa Y; Mori Y; Itano J; Taniguchi A; Senoo S; Kimura G; Tanimoto Y; Miyake K; Katsuta T; Kataoka M; Maeda Y; Kiura K; Miyahara N; Okayama Respiratory Disease Study Group Ordsg
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting IL-4 and IL-13 Receptors on Eosinophils in CRSwNP Patients: The Clinical Efficacy of Dupilumab.
    Piazzetta GL; Lobello N; Chiarella E; Rizzuti A; Pelaia C; Pelaia G; Lombardo N
    J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening olfaction under dupilumab in chronic rhinosinusitis with nasal polyps.
    Mauthe T; Meerwein CM; Ryser FS; Brühlmann C; Yalamanoglu A; Steiner UC; Soyka MB
    Rhinology; 2024 Jul; ():. PubMed ID: 38949841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective.
    Caminati M; Maule M; Benoni R; Bagnasco D; Beghè B; Braido F; Brussino L; Cameli P; Candeliere MG; Carpagnano GE; Costanzo G; Crimi C; D'Amato M; Del Giacco S; Guarnieri G; Yacoub MR; Micheletto C; Nicola S; Olivieri B; Pini L; Schiappoli M; Vaia R; Vianello A; Visca D; Spanevello A; Senna G
    Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps.
    Tanzini U; Rampi A; Vinciguerra A; Danè G; Yacoub MR; Bussi M; Trimarchi M
    Eur Arch Otorhinolaryngol; 2024 Jun; ():. PubMed ID: 38850424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.